Tech Center 3700 • Art Units: 3771 3773 3778 3782
This examiner grants 24% of resolved cases
Tan-Uyen Thi Ho is an examiner in Tech Center 3700 and Art Unit 3771. She has 54 resolved cases with an allowance rate of 24.1 percent. The median days to allowance is 1449, indicating the path to patent issuance. These metrics suggest that the 24.1 percent allowance rate is a primary factor for applicants to consider, alongside the 1449-day median.
The interview lift is 14.8 percent, which shows that direct communication can improve the chances of success compared to the 24.1 percent baseline. Given this baseline, practitioners should view the interview as a key part of their strategy. The 1449-day median pendency further emphasizes the need for proactive measures to overcome rejections. The 14.8 percent lift is a vital piece of data for those seeking to navigate this examiner's requirements. By focusing on verbal advocacy, applicants can improve their probability of a grant. With 54 cases resolved, these statistics provide a view of the prosecution environment in Art Unit 3771 and highlight the importance of a well-planned strategy. These figures offer a comprehensive view of the landscape for applications assigned to this examiner, where the 14.8 percent lift provides a measurable advantage.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18717955 | DELIVERY SYSTEMS FOR ENDOLUMINAL PROSTHESES AND METHODS OF USE | Non-Final OA | Boston Scientific Scimed, Inc. |
| 17543958 | MOTOR CONTROL AND FEEDBACK IN POWERED SURGICAL DEVICES | Final Rejection | Cilag GmbH International |
| 18940688 | MODULAR BIOPROSTHETIC VALVES AND METHODS FOR DESIGNING AND MAKING THEM | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18649749 | COVER FOR PROSTHETIC VALVE EXPANSION MECHANISM | Non-Final OA | EDWARDS LIFESCIENCES CORPORATION |
| 18627145 | ADJUSTABLE ANNULOPLASTY DEVICE | Non-Final OA | EDWARDS LIFESCIENCES CORPORATION |
| 18314759 | PROSTHETIC HEART VALVES WITH HERMETIC LAYERS OR VALVULAR STRUCTURES TO REDUCE THROMBOSIS RISK | Final Rejection | EDWARDS LIFESCIENCES CORPORATION |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy